Table 1 Clinicopathologic features of the neoadjuvant chemotherapy plus radiotherapy (NACT + RT) group and the concurrent chemoradiotherapy (CCRT) group of patients with ascending-type nasopharyngeal carcinoma (NPC)
Variable | NACTÂ +Â RT group | CCRT group | P value |
|---|---|---|---|
Total | 98 | 116 | Â |
Age (years) | 0.367 | ||
 Median | 44 | 45 |  |
 Range | 17–70 | 16–70 |  |
Gender [cases (%)] | 0.179 | ||
 Male | 84 (85.7) | 90 (77.6) |  |
 Female | 14 (14.3) | 26 (22.4) |  |
Histology [cases (%)] | 0.795 | ||
 WHO II | 5 (5.1) | 8 (6.9) |  |
 WHO III | 93 (94.9) | 108 (93.1) |  |
T stage [cases (%)]a | 0.131 | ||
 T3 | 43 (43.9) | 64 (55.2) |  |
 T4 | 55 (56.1) | 52 (44.8) |  |
N stage [cases (%)]a | 0.118 | ||
 N0 | 34 (34.7) | 47 (40.5) |  |
 N1 | 64 (65.3) | 69 (59.5) |  |
Total radiation dose (Gy) | 0.721 | ||
 Median | 70 | 69 |  |
 Range | 66–72 | 66–72 |  |
Overall duration of radiotherapy (days) | 0.674 | ||
 Median | 46 | 47 |  |
 Range | 40–49 | 42–51 |  |